Real-World Results from Talquetamab and Bispecific Antibodies | Carolina Schinke, MD | ASH 2023 

Interview with Carolina Schinke, MD from University of Arkansas for Medical Sciences at ASH 2023. Filmed December 9, 2023.
ASH ABSTRACT:
Updated Results of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies: Results of the Phase 1/2 MonumenTAL-1 Study
ash.confex.com/ash/2023/webpr...
The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree.org/myeloma/co...
Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: give.healthtree.org/campaign/...
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree.org/
Follow HealthTree:
healthtreeformm
healthtreeformultiplemyeloma
healthtreeformultiplemyeloma

Наука